Gyeonggi-do, South Korea

Won-Il Yoo

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Eyegene Inc.. Active years: 2015-2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Won-Il Yoo

Introduction

Won-Il Yoo is a prominent inventor located in Gyeonggi-do, South Korea. With a focus on advancements in medical treatments, he has made significant contributions through his innovative patents aimed at addressing vascular-related diseases. His work is essential for developing methods that could improve patient care and health outcomes.

Latest Patents

Won-Il Yoo holds two noteworthy patents. His latest patent involves a method for treating vascular-related diseases. This innovative approach includes administering a peptide with a specific sequence, Xaa-Gly-Asp, to subjects in need. The patent details how this peptide can help manage conditions such as edema and ischemia, which are caused by blood vessel issues like leakage, damage, or abnormal angiogenesis. This method showcases his commitment to advancing medical science through targeted and effective treatment options.

Career Highlights

Yoo is associated with Eyegene Inc., where he collaborates with a dedicated team to push the boundaries of medical research. His contributions emphasize the importance of innovative thinking and the application of scientific knowledge to real-world health challenges.

Collaborations

At Eyegene Inc., Won-Il Yoo has established collaborative relationships with colleagues such as Doo-Sik Kim and Yang-Je Cho. Working alongside talented professionals allows them to combine their expertise and insights, further enhancing the development of innovative solutions in the medical field.

Conclusion

In conclusion, Won-Il Yoo stands out as an influential inventor whose work focuses on significant health issues. His latest patents represent a dedication to improving treatments for vascular-related diseases, demonstrating the impact of innovation in the realm of healthcare. As he continues his career at Eyegene Inc., his future contributions are anticipated to bring further advancements and improvements to medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…